BR0213122A - Compostos policìclicos tendo atividade antitumoral - Google Patents

Compostos policìclicos tendo atividade antitumoral

Info

Publication number
BR0213122A
BR0213122A BR0213122-6A BR0213122A BR0213122A BR 0213122 A BR0213122 A BR 0213122A BR 0213122 A BR0213122 A BR 0213122A BR 0213122 A BR0213122 A BR 0213122A
Authority
BR
Brazil
Prior art keywords
antitumor activity
compounds
polycyclic compounds
ring
activity
Prior art date
Application number
BR0213122-6A
Other languages
English (en)
Portuguese (pt)
Inventor
Tsunehisa Aoyama
Kenichi Kawasaki
Miyako Masubuchi
Tatsuo Ohtsuka
Kiyoaki Sakata
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BR0213122A publication Critical patent/BR0213122A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BR0213122-6A 2001-10-05 2002-09-25 Compostos policìclicos tendo atividade antitumoral BR0213122A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01123908 2001-10-05
PCT/EP2002/010722 WO2003031444A1 (en) 2001-10-05 2002-09-25 Polycyclic compounds having anti-tumor activity

Publications (1)

Publication Number Publication Date
BR0213122A true BR0213122A (pt) 2004-09-21

Family

ID=8178868

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0213122-6A BR0213122A (pt) 2001-10-05 2002-09-25 Compostos policìclicos tendo atividade antitumoral

Country Status (16)

Country Link
US (1) US6680326B2 (https=)
EP (1) EP1436293B1 (https=)
JP (1) JP4369229B2 (https=)
KR (1) KR100676114B1 (https=)
CN (1) CN1284781C (https=)
AR (1) AR037327A1 (https=)
AT (1) ATE316971T1 (https=)
AU (1) AU2002342752B2 (https=)
BR (1) BR0213122A (https=)
CA (1) CA2461572C (https=)
DE (1) DE60209029T2 (https=)
ES (1) ES2256552T3 (https=)
MX (1) MXPA04003173A (https=)
PL (1) PL370530A1 (https=)
RU (1) RU2315050C2 (https=)
WO (1) WO2003031444A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6946472B2 (en) * 2002-04-30 2005-09-20 Hoffman-La Roche Inc. Polycyclic compounds exhibiting anti-tumor activities
US20060189893A1 (en) * 2005-01-06 2006-08-24 Diamics, Inc. Systems and methods for detecting abnormal cells
US20060161076A1 (en) * 2005-01-06 2006-07-20 Diamics, Inc. Systems and methods for collection of cell clusters
CN103204781B (zh) * 2013-03-14 2015-04-01 武汉大学 2,7–二取代芴酮衍生物及其制备方法与应用
CN110448555B (zh) * 2019-09-10 2020-10-23 河南省人民医院 多环化合物在制备抗肿瘤药物中的应用及抗肿瘤药物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW440562B (en) * 1994-05-20 2001-06-16 Taiho Pharmaceutical Co Ltd Condensed-indan derivative and pharmaceutically acceptable salts thereof
WO1998045272A1 (en) * 1997-04-07 1998-10-15 Latrobe University Topoisomerase inhibitors
FR2801309B1 (fr) 1999-11-18 2002-01-04 Adir Nouveaux composes analogues de la camptothecine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
ES2256552T3 (es) 2006-07-16
US6680326B2 (en) 2004-01-20
CA2461572A1 (en) 2003-04-17
WO2003031444A1 (en) 2003-04-17
AR037327A1 (es) 2004-11-03
JP4369229B2 (ja) 2009-11-18
US20030073691A1 (en) 2003-04-17
CN1610681A (zh) 2005-04-27
CN1284781C (zh) 2006-11-15
PL370530A1 (en) 2005-05-30
RU2004114245A (ru) 2005-06-27
MXPA04003173A (es) 2004-07-27
CA2461572C (en) 2011-02-15
KR100676114B1 (ko) 2007-02-02
RU2315050C2 (ru) 2008-01-20
EP1436293A1 (en) 2004-07-14
JP2005504846A (ja) 2005-02-17
AU2002342752B2 (en) 2007-11-15
EP1436293B1 (en) 2006-02-01
DE60209029D1 (de) 2006-04-13
ATE316971T1 (de) 2006-02-15
KR20040048926A (ko) 2004-06-10
DE60209029T2 (de) 2006-09-28

Similar Documents

Publication Publication Date Title
BR0008840A (pt) Derivados de camptotecina tendo atividade antitumoral
PL365783A1 (en) 4-amino-6-phenyl-pyrrolo[2,3-d]pyrimidine derivatives
BR0112711A (pt) Derivados de heteroarila e seus usos como medicamentos
BR0211289A (pt) Derivados de dolastatina 10
BR0308429A (pt) Aroilpiridinonas monocìclicas como agentes antiinflamatórios
BR0109861A (pt) Inibidores macrocìclicos de protease ns3-serina do vìrus da hepatite c compreendendo porções n-cìclicas p2
MX9700885A (es) Nuevas heteroariloxazolidinonas.
SV1999000047A (es) Nuevas dihidropirimidinas fef. lea 32792-sv
BR0109703A (pt) Derivados de piperazina
SE9904505D0 (sv) Novel compounds
BR0312232A (pt) Inibidores de caspases e seus usos
BR0306922A (pt) N-pirazinil-fenilsulfonamidas e seu uso no tratamento de doenças mediadas por quimocina
BR0209645A (pt) Oxazolo- e furopirimidinas e seu uso como medicamentos
ES2172937T3 (es) 21-hidroxi-6,19-oxidoprogesterona(21oh-6op) como medicamento para tratar el exceso de glucocorticoides.
BR0210531A (pt) Derivados de ácido sulfÈnico
BR0314195A (pt) Derivados de piridina substituìda como agentes antitumorais
WO2002010152A3 (de) Neue indolderivate und deren verwendung als arzneimittel
BR0213037A (pt) Derivados de pirimidina
ES2191449T3 (es) Derivados de ciclopentabenzofurano y su uso.
PT1030667E (pt) Utilizacao de mirtazapina para o fabrico de um medicamento para o tratamento de apenas do sono
IL166057A0 (en) Urea-substituted and urethane-substituted acylureas methods for the production thereof and their useas medicaments
BR0115139A (pt) Compostos bis-heterocìclicos com atividade antitumor e quimiossensibilizante
BR0213122A (pt) Compostos policìclicos tendo atividade antitumoral
NO20031410D0 (no) Antitumorterapi innbefattende distamycinderivater
BRPI0408380A (pt) derivados 7-imino de camptotecina tendo atividade antitumoral

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 12A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2273 DE 29/07/2014.